Ajanta Pharma gets USFDA approval for Entacapone, Parkinson’s disease tablet

Ajanta Pharma gets USFDA approval for Entacapone, Parkinson’s disease tablet

Ajanta Pharma got the final USFDA approval for Entacapone tablets which is used for treating the Parkinson’s disease. Ajanta Pharma said that it has received the final approval for Entacapone tablets from US FDA in a BSE filing. Entacapone tablets are bioequivalent generic version of Comtan tablets. Ajanta Pharma company said that they will launch […]

Novo Nordisk diabetes drug Victoza bags FDA approval for heart diseases

Novo Nordisk diabetes drug Victoza (liraglutide) has been approved by the US FDA for treating major cardiovascular diseases associated with type 2 diabetes.

Novo Nordisk diabetes drug Victoza bags FDA approval for heart diseases

Danish pharma firm Novo Nordisk has secured the approval from the U.S. Food and Drug Administration (FDA) for using its diabetes drug Victoza (liraglutide) to treat heart diseases associated with type 2 diabetes. The Novo Nordisk diabetes drug Victoza can now be used in the US to decrease the risk of major adverse cardiovascular (CV) […]

Merck lung cancer drug Keytruda plus chemo gets FDA approval for NSCLC

Merck’s cancer immunotherapy Keytruda (pembrolizumab) in combination with chemotherapy has been approved by the US Food and Drug Administration (FDA) as a first-line option for advanced lung cancer treatment in patients who didn’t take any medicines before for the disease.

Merck lung cancer drug Keytruda plus chemo gets FDA approval for NSCLC

Merck’s cancer immunotherapy Keytruda (pembrolizumab) in combination with chemotherapy has been approved by the US Food and Drug Administration (FDA) as a first-line option for advanced lung cancer treatment in patients who didn’t take any medicines before for the disease. The Keytruda chemotherapy combination has been approved to treat metastatic non-squamous non small cell lung […]

Genetech’s lucentis approved by US FDA for diabetic retinopathy treatment

The US FDA has approved lucentis (ranibizumab injection) for diabetic retinopathy treatment. Read the Lucentis FDA approval story in our pharma news updates section at DailyHealthNeeds.com.

Genetech’s lucentis approved by US FDA for diabetic retinopathy treatment

Genentech’s injection to treat diabetic retinopathy, lucentis (ranibizumab injection) has been approved by the U.S. Food and Drug Administration (FDA). The approved dosage of ranibizumab injection to be administered monthly once is 0.3mg for treating all types of diabetic retinopathy. Diabetic Retinopathy Treatment with Lucentis Injection Lucentis FDA approval means that the drug is now […]

APAC Biotech’s Immuno-oncology drug Apceden gets approved in India

The Indian FDA (CDSCO - Central Drugs Standard Control Organization) has granted a commercial license to APAC Biotech to market Apceden, a Dendritic cell-based autologous Immuno-oncology drug for prostate, ovarian, colo-rectal and non small cell lung carcinoma form of cancers.

APAC Biotech’s Immuno-oncology drug Apceden gets approved in India

The Indian FDA (CDSCO – Central Drugs Standard Control Organization) has granted a commercial license to APAC Biotech to market Apceden, a Dendritic cell-based autologous Immuno-oncology drug for prostate, ovarian, colo-rectal and non small cell lung carcinoma form of cancers. Following a stringent review of the application submitted by the Indian biotechnology company, the Indian […]

Neurocrine’s Ingrezza approved by FDA for tardive dyskinesia treatment

The US Food and Drug Administration (FDA) has approved for Ingrezza (valbenazine) capsules developed by Neurocrine Biosciences for the treatment of tardive dyskinesia patients.

Neurocrine’s Ingrezza approved by FDA for tardive dyskinesia treatment

The US Food and Drug Administration (FDA) has approved for Ingrezza (valbenazine) capsules developed by Neurocrine Biosciences for the treatment of tardive dyskinesia patients. A selective vesicular monoamine transporter 2 (VMAT2) inhibitor, Ingrezza has become the first drug to be approved by the regulator to treat adults suffering from tardive dyskinesia. VMAT2 is a protein […]

Genentech MS drug Ocrevus approved by FDA for multiple sclerosis treatment

Roche Group’s subsidiary Genentech has secured the US FDA approval for its multiple sclerosis drug, Ocrevus (ocrelizumab) for treating both relapsing and primary progressive variants of the chronic disease through intravenous infusion.

Genentech MS drug Ocrevus approved by FDA for multiple sclerosis treatment

Roche Group’s subsidiary Genentech has secured the US FDA approval for its multiple sclerosis drug, Ocrevus (ocrelizumab) for treating both relapsing and primary progressive variants of the chronic disease through intravenous infusion. The FDA approval has made the Genentech MS drug Ocrevus as the first and only therapy available for the two forms of multiple […]

Dupixent eczema injection gets FDA approval for atopic dermatitis treatment

Dupixent (dupilumab), the co-developed eczema injection from pharma giants Sanofi and Regeneron Pharmaceuticals, has got the US FDA approval for the treatment of moderate-to-severe atopic dermatitis (AD) in adult patients.

Dupixent eczema injection gets FDA approval for atopic dermatitis treatment

Dupixent (dupilumab), the co-developed eczema injection from pharma giants Sanofi and Regeneron Pharmaceuticals, has got the US FDA approval for the treatment of moderate-to-severe atopic dermatitis (AD) in adult patients. Dupixent eczema injection with that has become the first ever biologic medicine approved for atopic dermatitis treatment in patients whose disease is not managed adequately […]

1 2 3 5